(Reuters) -MapLight is aiming to raise up to $250.8 million in an initial public offering in the U.S., the biopharmaceutical company said on Monday.
U.S. IPO activity has picked up in recent months, reversing a slowdown earlier in the year when trade-policy uncertainty curbed momentum, as recent listings have attracted strong investor demand.
MapLight will list on the Nasdaq under the symbol “MPLT.”
Morgan Stanley, Jefferies, Leerink Partners and Stifel are the underwriters for the offering.
(Reporting by Prakhar Srivastava in Bengaluru; Editing by Sahal Muhammed)
Brought to you by www.srnnews.com
